1Vaezi MF,Hicks DM,Abelson TI,et al.Laryngeal signs and symptoms and gastroesophageal reflux disease:a critical assessment of cause and effect association.Clin Gastroenterol Hepa tol,2003,1:333-344. 被引量：1
2Galli J,Agostino S,Calo L,et al.Gastro esophageal reflux and laryngeal phlogistic disorders:clinical evaluation and multielectrode pH monitoring.Acta Otorhinolaryngol Ital,2001,21:306-311. 被引量：1
4Jacob P,Kahrilas PJ,Herzon G.Proximal esophageal pH-metry in patients with reflux laryngitis.Gastroenterology,1991,100:305-310. 被引量：1
5Poelmans J,Feenstra L,Demedts I,et al,The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear,nose,and throat symptoms.Am J Gastroenterol,2004,99:1419-1426. 被引量：1
6El-Serag HB,Lee P,Buchner A,et al.Lansoprazole treatment of patients with chronic idiopathic laryngitis:a placebo-controlled trial.AmJ Gastroenterol,2001,96:979-983. 被引量：1
7Noordzij IP,Khidr A,Evans BA,et al.Evaluation of omeprazole in the treatment of reflux laryngitis:a prospective,placebo-controlled,randomized,double blind study.Laryngoscope,2001,111:2147-2151. 被引量：1
8Toohill RJ,Kuhn JC.Role of refluxed acid in pathogenesis of laryngeal disorders.AmJ Med,1997,103:100S-106S. 被引量：1
9Hennig A,Neumann A,Schultz-Coulon HJ.Stenosing gastric laryngitis in infancy.HNO,2004,52:352-355. 被引量：1
10Kahrilas PJ,Quigley EM,Castell DO,et al.The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.Aliment Pharmacol Ther,2000,14:1503-1509. 被引量：1
